DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC.

Int J Mol Sci · 2023 · PMC10219140 · PMID 37240218

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The median overall survival of patients without a BRCA1/2 mutation was 29 months, while patients with a BRCA1/2 mutation had an OS that was 3 months longer, thus resulting in 32 months (but it did not reach statistical significance).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.